Akebia Therapeutics, Inc. - Common Stock (AKBA)

CUSIP: 00972D105

Q3 2017 13F Holders as of 30 Sep 2017

Type / Class
Equity / Common Stock
Shares outstanding
263,222,327
Total 13F shares
30,165,358
Share change
+2,938,463
Total reported value
$593,266,094
Put/Call ratio
0%
Price per share
$19.67
Number of holders
118
Value change
+$67,324,611
Number of buys
80
Number of sells
37

Sponsored

Quarterly Holders Quick Answers

What is CUSIP 00972D105?
CUSIP 00972D105 identifies AKBA - Akebia Therapeutics, Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of AKBA - Akebia Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
EAGLE ASSET MANAGEMENT INC
13F
Company
1.3%
3,525,685
$50,664,000 30 Jun 2017
13F
BlackRock Finance, Inc.
13F
Company
1%
2,744,607
$39,440,000 30 Jun 2017
13F
Nantahala Capital Management, LLC
13F
Company
0.82%
2,148,623
$30,876,000 30 Jun 2017
13F
Novo Holdings A/S
13F
Company
0.69%
1,814,289
$26,071,000 30 Jun 2017
13F
VANGUARD GROUP INC
13F
Company
0.55%
1,436,163
$20,638,000 30 Jun 2017
13F
FIRST MANHATTAN CO. LLC.
13F
Company
0.45%
1,188,500
$17,078,000 30 Jun 2017
13F
PERCEPTIVE ADVISORS LLC
13F
Company
0.42%
1,100,000
$15,808,000 30 Jun 2017
13F
FMR LLC
13F
Company
0.39%
1,036,955
$14,901,000 30 Jun 2017
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
0.39%
1,025,300
$14,734,000 30 Jun 2017
13F
STATE STREET CORP
13F
Company
0.36%
946,888
$13,604,000 30 Jun 2017
13F
RA CAPITAL MANAGEMENT, L.P.
13F
Company
0.32%
836,337
$12,018,000 30 Jun 2017
13F
FARALLON CAPITAL MANAGEMENT LLC
13F
Company
0.28%
730,000
$10,490,000 30 Jun 2017
13F
MORGAN STANLEY
13F
Company
0.27%
702,704
$10,097,000 30 Jun 2017
13F
Numeric Investors LLC
13F
Company
0.24%
621,967
$8,938,000 30 Jun 2017
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
0.22%
586,914
$8,434,000 30 Jun 2017
13F
NORTHERN TRUST CORP
13F
Company
0.16%
424,093
$6,094,000 30 Jun 2017
13F
Marshall Wace North America L.P.
13F
Company
0.15%
389,770
$5,457,000 30 Jun 2017
13F
ACADIAN ASSET MANAGEMENT LLC
13F
Company
0.14%
370,738
$5,327,000 30 Jun 2017
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.12%
328,181
$4,715,000 30 Jun 2017
13F
Crawford Lake Capital Management, LLC
13F
Company
0.12%
323,874
$4,654,000 30 Jun 2017
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.11%
293,845
$4,222,000 30 Jun 2017
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.11%
291,890
$4,195,000 30 Jun 2017
13F
DEUTSCHE BANK AG\
13F
Company
0.1%
275,191
$3,953,000 30 Jun 2017
13F
TIAA CREF INVESTMENT MANAGEMENT LLC
13F
Company
0.1%
252,123
$3,623,000 30 Jun 2017
13F
Informed Momentum Co LLC
13F
Company
0.08%
223,140
$3,207,000 30 Jun 2017
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.08%
206,476
$2,968,000 30 Jun 2017
13F
Bank of New York Mellon Corp
13F
Company
0.08%
199,818
$2,872,000 30 Jun 2017
13F
WELLINGTON MANAGEMENT GROUP LLP
13F
Company
0.07%
190,436
$2,736,000 30 Jun 2017
13F
DAFNA Capital Management LLC
13F
Company
0.05%
135,738
$1,951,000 30 Jun 2017
13F
Alyeska Investment Group, L.P.
13F
Company
0.05%
125,000
$1,796,000 30 Jun 2017
13F
Monashee Investment Management LLC
13F
Company
0.05%
125,000
$1,796,000 30 Jun 2017
13F
Laurion Capital Management LP
13F
Company
0.05%
121,678
$1,749,000 30 Jun 2017
13F
Invesco Ltd.
13F
Company
0.05%
120,578
$1,734,000 30 Jun 2017
13F
UBS Group AG
13F
Company
0.04%
111,272
$1,599,000 30 Jun 2017
13F
NORGES BANK
13F
Company
0.04%
100,000
$1,437,000 30 Jun 2017
13F
MARSHALL WACE, LLP
13F
Company
0.04%
97,294
$1,362,000 30 Jun 2017
13F
AMERICAN CENTURY COMPANIES INC
13F
Company
0.04%
92,620
$1,331,000 30 Jun 2017
13F
WELLS FARGO & COMPANY/MN
13F
Company
0.03%
88,091
$1,266,000 30 Jun 2017
13F
AMERIPRISE FINANCIAL INC
13F
Company
0.03%
84,655
$1,218,000 30 Jun 2017
13F
PARAMETRIC PORTFOLIO ASSOCIATES LLC
13F
Company
0.03%
74,124
$1,065,000 30 Jun 2017
13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP
13F
Company
0.03%
72,701
$1,045,000 30 Jun 2017
13F
Russell Investments Group, Ltd.
13F
Company
0.03%
70,069
$1,006,000 30 Jun 2017
13F
OXFORD ASSET MANAGEMENT LLP
13F
Company
0.03%
69,000
$992,000 30 Jun 2017
13F
TEACHERS ADVISORS, LLC
13F
Company
0.03%
68,355
$982,000 30 Jun 2017
13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM
13F
Company
0.02%
65,342
$939,000 30 Jun 2017
13F
JOHNSON INVESTMENT COUNSEL INC
13F
Company
0.02%
63,321
$909,000 30 Jun 2017
13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM
13F
Company
0.02%
59,000
$848,000 30 Jun 2017
13F
Piermont Capital Management Inc.
13F
Company
0.02%
55,075
$791,000 30 Jun 2017
13F
Foresite Capital Management II, LLC
13F
Company
0.02%
50,000
$719,000 30 Jun 2017
13F
NEW YORK STATE COMMON RETIREMENT FUND
13F
Company
0.02%
48,100
$691,000 30 Jun 2017
13F

Institutional Holders of Akebia Therapeutics, Inc. - Common Stock (AKBA) as of Q3 2017

As of 30 Sep 2017, Akebia Therapeutics, Inc. - Common Stock (AKBA) was held by 118 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 30,165,358 shares. The largest 10 holders included BlackRock Inc., EAGLE ASSET MANAGEMENT INC, Novo Holdings A/S, VANGUARD GROUP INC, PERCEPTIVE ADVISORS LLC, RENAISSANCE TECHNOLOGIES LLC, Nantahala Capital Management, LLC, STATE STREET CORP, FMR LLC, and FIRST MANHATTAN CO. This page lists 118 institutional shareholders reporting positions in this security for the Q3 2017 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q3 2017 vs Q2 2017 Across Filers

Q2 2017 holders
115
Q3 2017 holders
118
Holder diff
3
Investor Q2 2017 Shares Q3 2017 Shares Share Diff Share Chg % Q2 2017 Value $ Q3 2017 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.